Side-by-side comparison of AI visibility scores, market position, and capabilities
Beiersdorf's global men's grooming line in 200+ countries; dermatologically tested face care, shaving, and deodorant products competing with Gillette and L'Oréal Men Expert.
NIVEA MEN is the men's grooming line of NIVEA, the flagship skincare brand of Beiersdorf AG (ETR: BEI) — producing face care products (moisturizers, exfoliators, anti-aging serums), shaving preparations (gels, foams, sensitive post-shave balms), body care (lotions, shower gels), and deodorants formulated specifically for men's skin characteristics and preferences. As one of the most widely distributed men's skincare brands globally, NIVEA MEN is sold in pharmacies, supermarkets, and mass retailers across 200+ countries, making it accessible in markets where premium grooming brands aren't widely distributed.\n\nNIVEA MEN's product development emphasizes dermatologically tested formulas that address specific men's skin concerns — post-shave irritation, razor burn, and skin sensitivity are addressed through products like the Q10 Anti-Wrinkle line and Sensitive line. The brand balances clinical efficacy credentials (Beiersdorf's skin research heritage, the same underlying brand equity as NIVEA skincare) with straightforward, no-nonsense positioning that appeals to men who aren't engaged with the complexity of multi-step skincare routines.\n\nIn 2025, NIVEA MEN competes in the men's grooming market with Gillette (P&G, gillette.com), Old Spice (P&G), L'Oréal Men Expert, and premium brands like Jack Black and Kiehl's for male skincare and grooming product market share. The men's skincare category has grown substantially as male grooming routines have expanded from basic shaving to multi-step skincare influenced by K-beauty trends and social media. NIVEA MEN's mass market positioning allows it to capture the mainstream adoption of this trend at accessible price points. Beiersdorf's 2025 strategy for NIVEA MEN focuses on growing the premium face care segment, expanding anti-aging product lines for men (a growing category), and digital marketing to younger male consumers engaging with grooming content on social media.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.